Covered recipient · General Payments record
MILAD I SHAKER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$132.46
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $132.46 | 10 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $36.46 | 3 |
| E.R. Squibb & Sons, L.L.C. | $30.67 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.02 | 2 |
| PFIZER INC. | $24.73 | 2 |
| GlaxoSmithKline, LLC. | $13.58 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $132.46 | 10 |
Payment records · PY2018 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $16.49 | 03/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 572100089 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.18 | 08/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 572100091 | CMS |
| GlaxoSmithKline, LLC. | $13.58 | 04/23/2018 | Food and Beverage | Undisputed | 01/23/2026 | 594300099 | CMS |
| Novartis Pharmaceuticals Corporation | $11.23 | 02/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 608696831 | CMS |
| Novartis Pharmaceuticals Corporation | $15.79 | 03/19/2018 | Food and Beverage | Undisputed | 01/23/2026 | 608696829 | CMS |
| Novo Nordisk Inc | $13.50 | 03/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 588729141 | CMS |
| Novo Nordisk Inc | $11.71 | 07/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 588729139 | CMS |
| Novo Nordisk Inc | $11.25 | 09/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 588729137 | CMS |
| PFIZER INC. | $12.94 | 10/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610755607 | CMS |
| PFIZER INC. | $11.79 | 10/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610460057 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.